Cargando…

Traversing Their Path to the Peripheral Smear: The Journey of Traumatized Red Blood Cells

Background  Thrombotic microangiopathy encompasses a wide range of conditions, of which thrombotic thrombocytopenic purpura being a medical emergency requires prompt intervention, with schistocytes being a reliable morphological indicator of microvascular injury. However, there are conditions other...

Descripción completa

Detalles Bibliográficos
Autores principales: Mannem, Chethana, Saher, Tuba, Ramdas, Gayathri Bilagali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical and Scientific Publishers Pvt. Ltd. 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411180/
https://www.ncbi.nlm.nih.gov/pubmed/37564225
http://dx.doi.org/10.1055/s-0043-1764481
_version_ 1785086610465882112
author Mannem, Chethana
Saher, Tuba
Ramdas, Gayathri Bilagali
author_facet Mannem, Chethana
Saher, Tuba
Ramdas, Gayathri Bilagali
author_sort Mannem, Chethana
collection PubMed
description Background  Thrombotic microangiopathy encompasses a wide range of conditions, of which thrombotic thrombocytopenic purpura being a medical emergency requires prompt intervention, with schistocytes being a reliable morphological indicator of microvascular injury. However, there are conditions other than thrombotic microangiopathic anemia where schistocytes can be seen in large numbers. These nonthrombotic microangiopathic conditions are broadly grouped under cytoskeletal abnormalities, mechanical damage, and thermal injuries. Automated methods in schistocyte evaluation have shown varied reproducibility requiring manual identification. International Council for Standardization in Hematology (ICSH) recommends standardized morphological criteria and quantitative assessment as a percentage after counting at least 1,000 red blood cells in optimal areas of smear to reduce interobserver variability. Objectives  The aim of this study was to evaluate and quantitate schistocytes in thrombotic microangiopathic and nonthrombotic microangiopathic groups using ICSH guidelines and to evaluate interobserver reproducibility of manual schistocyte count. Materials and Methods  Overall, 157 peripheral blood smears showing schistocytes were studied by two independent observers using ICSH recommendations on light microscopy. The hematological findings were correlated with clinical diagnosis and other relevant investigations. Results  Schistocytes were observed in five cases of thrombotic microangiopathic anemia and 152 cases of nonthrombotic microangiopathic anemia. Schistocyte count in thrombotic microangiopathic anemia and nonthrombotic microangiopathic anemia groups with mean (±standard deviation) value was 2.28 ± 2.65% and 0.76 ± 0.67%, respectively ( p  < 0.001). The correlation coefficient between the two observers was 0.59 (confidence interval = 0.966–1.346) showing an excellent agreement on the reproducibility of schistocytes by application of ICSH guidelines. Conclusion  Percentage of schistocytes more than 1% is a robust morphological indicator for diagnosis of thrombotic microangiopathic anemia in adults. Strict application of ICSH guidelines reduces interobserver bias.
format Online
Article
Text
id pubmed-10411180
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Thieme Medical and Scientific Publishers Pvt. Ltd.
record_format MEDLINE/PubMed
spelling pubmed-104111802023-08-10 Traversing Their Path to the Peripheral Smear: The Journey of Traumatized Red Blood Cells Mannem, Chethana Saher, Tuba Ramdas, Gayathri Bilagali J Lab Physicians Background  Thrombotic microangiopathy encompasses a wide range of conditions, of which thrombotic thrombocytopenic purpura being a medical emergency requires prompt intervention, with schistocytes being a reliable morphological indicator of microvascular injury. However, there are conditions other than thrombotic microangiopathic anemia where schistocytes can be seen in large numbers. These nonthrombotic microangiopathic conditions are broadly grouped under cytoskeletal abnormalities, mechanical damage, and thermal injuries. Automated methods in schistocyte evaluation have shown varied reproducibility requiring manual identification. International Council for Standardization in Hematology (ICSH) recommends standardized morphological criteria and quantitative assessment as a percentage after counting at least 1,000 red blood cells in optimal areas of smear to reduce interobserver variability. Objectives  The aim of this study was to evaluate and quantitate schistocytes in thrombotic microangiopathic and nonthrombotic microangiopathic groups using ICSH guidelines and to evaluate interobserver reproducibility of manual schistocyte count. Materials and Methods  Overall, 157 peripheral blood smears showing schistocytes were studied by two independent observers using ICSH recommendations on light microscopy. The hematological findings were correlated with clinical diagnosis and other relevant investigations. Results  Schistocytes were observed in five cases of thrombotic microangiopathic anemia and 152 cases of nonthrombotic microangiopathic anemia. Schistocyte count in thrombotic microangiopathic anemia and nonthrombotic microangiopathic anemia groups with mean (±standard deviation) value was 2.28 ± 2.65% and 0.76 ± 0.67%, respectively ( p  < 0.001). The correlation coefficient between the two observers was 0.59 (confidence interval = 0.966–1.346) showing an excellent agreement on the reproducibility of schistocytes by application of ICSH guidelines. Conclusion  Percentage of schistocytes more than 1% is a robust morphological indicator for diagnosis of thrombotic microangiopathic anemia in adults. Strict application of ICSH guidelines reduces interobserver bias. Thieme Medical and Scientific Publishers Pvt. Ltd. 2023-03-27 /pmc/articles/PMC10411180/ /pubmed/37564225 http://dx.doi.org/10.1055/s-0043-1764481 Text en The Indian Association of Laboratory Physicians. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
spellingShingle Mannem, Chethana
Saher, Tuba
Ramdas, Gayathri Bilagali
Traversing Their Path to the Peripheral Smear: The Journey of Traumatized Red Blood Cells
title Traversing Their Path to the Peripheral Smear: The Journey of Traumatized Red Blood Cells
title_full Traversing Their Path to the Peripheral Smear: The Journey of Traumatized Red Blood Cells
title_fullStr Traversing Their Path to the Peripheral Smear: The Journey of Traumatized Red Blood Cells
title_full_unstemmed Traversing Their Path to the Peripheral Smear: The Journey of Traumatized Red Blood Cells
title_short Traversing Their Path to the Peripheral Smear: The Journey of Traumatized Red Blood Cells
title_sort traversing their path to the peripheral smear: the journey of traumatized red blood cells
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411180/
https://www.ncbi.nlm.nih.gov/pubmed/37564225
http://dx.doi.org/10.1055/s-0043-1764481
work_keys_str_mv AT mannemchethana traversingtheirpathtotheperipheralsmearthejourneyoftraumatizedredbloodcells
AT sahertuba traversingtheirpathtotheperipheralsmearthejourneyoftraumatizedredbloodcells
AT ramdasgayathribilagali traversingtheirpathtotheperipheralsmearthejourneyoftraumatizedredbloodcells